A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

NCT04071158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

713

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infection

Interventions

BIOLOGICAL: RSV Vaccine
BIOLOGICAL: Tdap
BIOLOGICAL: Placebo

Sponsor

Pfizer